Highlights and Quick Summary
- Annual 3Y Operating CF Growth (CAGR) for 2022 was 0.0%
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Operating CF Growth (CAGR) of Design Therapeutics, Inc.
Most recent 3Y Operating CF Growth (CAGR)of DSGN including historical data for past 10 years.Interactive Chart of 3Y Operating CF Growth (CAGR) of Design Therapeutics, Inc.
Design Therapeutics, Inc. 3Y Operating CF Growth (CAGR) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | 0.0% |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology